FDA approves Helicobacter pylori breath test

Article

A breath test that detects Helicobacter pylori infection has been approved by the US FDA for use in children aged 3 to 17 years.

A breath test that detects bacterial Helicobacter pylori infection has been approved by the US Food and Drug Administration (FDA) for use in children aged 3 to 17 years. H pylori causes chronic active, chronic persistent, and atrophic gastritis duodenal and gastric ulcers in adults and children.

FDA based its approval of the breath test for children on a multicenter study of 176 patients that demonstrated 95.8% sensitivity and 99.2% specificity for H pylori bacteria compared with a composite reference. A follow-up study 1 to 6 months after therapy showed 83.3% sensitivity and 100% specificity in posttreatment monitoring.

The Centers for Disease Control and Prevention estimates that two-thirds of the world's population is infected with H pylori. Most of those infected have no symptoms.

Recent Videos
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Jennifer Soung, MD reacts to FDA approval of roflumilast foam 0.3%
Supporting mental health in pediatric primary care with Victor Carrion, MD
Discussing social media and potential nutrition impacts with Colleen Sloan, PA-C, RDN
Jenna Marcovitz, MA explains how music therapy helps in pediatric care
Peter S. Jensen, MD
Suzanne Hollander, MS, RD, LDN, Senior Clinical Nutrition Specialist, Boston Children's Hospital | Image credit: Boston Children's
© 2025 MJH Life Sciences

All rights reserved.